Log in to save to my catalogue

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft mode...

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft mode...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa8568459fe44266838e21ee8914e3f8

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model

About this item

Full title

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

Journal title

EJNMMI Research, 2018-05, Vol.8 (1), p.39-13, Article 39

Language

English

Formats

Publication information

Publisher

Berlin/Heidelberg: Springer Berlin Heidelberg

More information

Scope and Contents

Contents

Background
The protein cross-linking enzyme tissue transglutaminase (TG2; EC 2.3.2.13) is associated with the pathogenesis of various diseases, including cancer. Recently, the synthesis and initial evaluation of two high-potential radiolabelled irreversible TG2 inhibitors were reported by us. In the present study, these two compounds were evalua...

Alternative Titles

Full title

In vivo evaluation of two tissue transglutaminase PET tracers in an orthotopic tumour xenograft model

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_doaj_primary_oai_doaj_org_article_fa8568459fe44266838e21ee8914e3f8

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_doaj_primary_oai_doaj_org_article_fa8568459fe44266838e21ee8914e3f8

Other Identifiers

ISSN

2191-219X

E-ISSN

2191-219X

DOI

10.1186/s13550-018-0388-2

How to access this item